Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Cardlytics Inc (NASDAQ: CDLX) closed at $1.29 up 5.74% from its previous closing price of $1.22. In other words, the price has increased by $5.74 from its previous closing price. On the day, 0.61 million shares were traded. CDLX stock price reached its highest trading level at $1.315 during the session, while it also had its lowest trading level at $1.205.
Ratios:
For a deeper understanding of Cardlytics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.14 and its Current Ratio is at 1.14.
Upgrades & Downgrades
In the most recent recommendation for this company, Evercore ISI on October 11, 2024, initiated with a In-line rating and assigned the stock a target price of $4.
On August 16, 2024, Northland Capital Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $5.
BofA Securities Downgraded its Neutral to Underperform on August 15, 2024, whereas the target price for the stock was revised from $4 to $3.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 05 ’26 when Lynton Nicholas Hollmeyer sold 6,253 shares for $1.17 per share. The transaction valued at 7,316 led to the insider holds 122,862 shares of the business.
Gupta Amit sold 5,807 shares of CDLX for $6,794 on Jan 05 ’26. The Chief Executive Officer now owns 506,852 shares after completing the transaction at $1.17 per share. On Jan 05 ’26, another insider, DeSieno Alexis, who serves as the Chief Financial Officer of the company, sold 8,607 shares for $1.17 each. As a result, the insider received 10,070 and left with 201,159 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 69732944 and an Enterprise Value of 247204944. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28. Its current Enterprise Value per Revenue stands at 0.984 whereas that against EBITDA is -9.951.
Stock Price History:
The Beta on a monthly basis for CDLX is 1.05, which has changed by -0.60130715 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, CDLX has reached a high of $4.05, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 3.20%, while the 200-Day Moving Average is calculated to be -20.87%.
Shares Statistics:
For the past three months, CDLX has traded an average of 969.71K shares per day and 1115560 over the past ten days. A total of 53.81M shares are outstanding, with a floating share count of 51.29M. Insiders hold about 5.12% of the company’s shares, while institutions hold 42.22% stake in the company. Shares short for CDLX as of 1767139200 were 5954069 with a Short Ratio of 6.14, compared to 1764288000 on 5610970. Therefore, it implies a Short% of Shares Outstanding of 5954069 and a Short% of Float of 12.810000999999998.
Earnings Estimates
Cardlytics Inc (CDLX) is presently subject to a detailed evaluation by 2.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.11 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.48 and -$0.59 for the fiscal current year, implying an average EPS of -$0.54. EPS for the following year is -$0.31, with 3.0 analysts recommending between -$0.2 and -$0.42.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $55.17M this quarter.It ranges from a high estimate of $57.95M to a low estimate of $53.02M. As of. The current estimate, Cardlytics Inc’s year-ago sales were $74MFor the next quarter, 4 analysts are estimating revenue of $49.4M. There is a high estimate of $52.5M for the next quarter, whereas the lowest estimate is $47.7M.
A total of 5 analysts have provided revenue estimates for CDLX’s current fiscal year. The highest revenue estimate was $237.39M, while the lowest revenue estimate was $230.2M, resulting in an average revenue estimate of $232.79M. In the same quarter a year ago, actual revenue was $278.3MBased on 5 analysts’ estimates, the company’s revenue will be $220.24M in the next fiscal year. The high estimate is $237.2M and the low estimate is $202.24M.
